Navigation Links
Enzyme's second messenger contributes to cell overgrowth
Date:9/26/2007

Scientists at the University of California, San Diego (UCSD) School of Medicine have uncovered a novel pathway by which hormones elevated in inflammation, cancer and cell injury act on cells to stimulate their growth.

The research team led by Joan Heller Brown, Ph.D., professor and chair of the department of pharmacology at UCSD, has demonstrated in a mouse model that a newly discovered subtype of the phospholipase C (PLC) family of enzymes, called PLC-epsilon, has the unique ability to activate a second and distinct signaling pathway that cells require for proliferation. The study is currently on line in advance of publication by the Proceedings of the National Academy of Science (PNAS.)

The studies reported in the PNAS demonstrate that in the cell, hormones that activate small G proteins are highly dependent on PLC- to generate second messengers, said Heller Brown. In addition, and more surprisingly, we discovered that this enzyme is required for cell growth because it serves a second function when activated by hormones.

Many intracellular signaling proteins work as molecular switches. The reception of a signal activates them and causes them to pass the signal through the cell, after which they can be switched off until another signal is received. G proteins are a commonly used form of switch, activated by the binding of guanine nucleotides. PLCs normal role is delivering signals from outside the cell to inside the cell by generating second messengers that tell cells to contract and secrete. But these signals alone are not enough to cause cells to increase their growth. The first author of the paper, Simona Citro, Ph.D., and colleagues found that PLC- uniquely activates a second and distinctly different signaling cascade. This second signal catalyzes activation of a Ras family of small G proteins associated with cell growth.

In combination with the first set of signals, this can lead to cell proliferation and could contribute to inflammation or cancer if left unchecked, said Citro.

PLC plays a critical role in physiological processes including heart function, cell secretion and blood pressure control, so one would not normally want to block its activity, added Heller Brown. The UCSD researchers discovery may enable scientists to target this novel PLC isoform or inhibit only its second function, preventing pathological responses while leaving PLCs critical positive role intact.


'/>"/>

Contact: Debra Kain
ddkain@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Related medicine news :

1. Smoking Hazardous To The Enzymes System In Lungs
2. Bad Enzymes Found To Enable Brain Recovery Following Stroke
3. New Role of COX Enzymes Discovered
4. Immune System Gears Up by Specific Enzymes
5. Study Attributes Elevated Liver Enzymes in HIV/hepatitis to Coinfection Rather Than Antiretrovirals
6. Surgeons implant second artificial heart
7. Second hope for men with erectile dysfunction
8. Second SARS suspect fuels worry in India
9. Animals Can give us a second chance at life
10. Animals can give us a second chance at life
11. The Harmful Effects Of Secondhand Smoke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... , ... My T Chai, a South African company that creates a number ... RevNutrition.com, a popular website specializing in sales of nutritional products. , Chai tea ... Siam. It spread across Asia and Africa quickly, and today recipes vary from region ...
(Date:4/24/2017)... PORT RICHEY, Fla. (PRWEB) , ... April 24, ... ... Control and Prevention (CDC), rising prescription opioid overdose deaths now claim the lives ... has slashed its civil case filings against drug manufacturers, distributors, pharmacies and prescribers ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... Rod Burkett, ... Senior Housing News website. , Rod has been at the forefront of Gardant since ... culture. As CEO, Rod has overseen the opening of more than 40 new senior ...
(Date:4/24/2017)... ... April 24, 2017 , ... Come to PAINWeekEnd (PWE) Tampa ... Walter Blvd, for an educational and exciting 2-day program. , An attendee at ... this before they approach patients” about the course entitled Ain't Misbehavin': Decreasing and Managing ...
(Date:4/24/2017)... ... April 24, 2017 , ... A new global study of ... student well-being has seriously declined. "When disenfranchised youth from the heart of our ... State to turn the historic multi-ethnic and multi-religious powerhouses of the Middle East ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
(Date:4/19/2017)... , April 19, 2017 Global Prostate ... report on the prostate cancer therapeutics market analyzes ... market. Increasing prevalence of prostate cancer, launch of ... the development of new drugs & therapeutic biological ... drug due to lesser side effects are some ...
(Date:4/19/2017)...  New research provides evidence that an old drug may ... study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... disease, the oral drug levodopa has long been considered the ... the disease progresses, the effects of the medication can partially ...
Breaking Medicine Technology: